Evidence map›Paper›PMID 41730195›Full record

ArticleJMIR AI2026

Explaining the Slow Adoption of AI Innovations in Health Care: Network Analysis Approach.

Petra Apell, Sara Locher, Annie Milde, Henrik Eriksson

Abstract read
In one paragraph

Article in JMIR AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Petra Apell *Department of Technology Management and Economics, Chalmers University of Technology, Göteborg, Sweden.ORCID https://orcid.org/0000-0002-5296-6718
Sara Locher *Department of Technology Management and Economics, Chalmers University of Technology, Göteborg, Sweden.ORCID https://orcid.org/0009-0003-0595-2625
Annie Milde *Department of Technology Management and Economics, Chalmers University of Technology, Göteborg, Sweden.ORCID https://orcid.org/0009-0005-8103-1662
Henrik Eriksson *Department of Technology Management and Economics, Chalmers University of Technology, Göteborg, Sweden.ORCID https://orcid.org/0000-0001-6464-7231

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundArtificial intelligence (AI) is a topic of considerable hype, with many actors sensing its high potential for health care applications. Despite this, the adoption has been slow, with few applications being implemented in clinical practice.

objectiveThe aim of our study was to investigate the challenges associated with using AI in health care, as well as provide suggestions for how further adoption of AI within health care organizations can be facilitated.

methodsA qualitative case study with a mixed methods approach was conducted at one of Sweden's largest hospitals. Regulatory approved AI medical devices were analyzed, and primary qualitative data from 14 expert interviews were collected and cross-referenced with secondary quantitative data. The framework of technological innovation systems was used to analyze the system factors and their dynamics to identify blocking mechanisms and areas for improvement.

resultsThe challenges related to knowledge development, diffusion, legitimation, and resource mobilization could trigger a cascade of positive activities, thereby significantly enhancing the overall performance of the innovation system. Creating dedicated testing environments to evaluate safety and efficacy would facilitate the routine clinical use and reinforce the use of AI innovations in health care organizations.

conclusionsThis analysis shows that the adoption of AI health care technology innovations can be accelerated through targeted strategies and supportive mechanisms triggering virtuous cycles that facilitate clinical validation and generate compelling use cases. The interconnection between guidance of search and entrepreneurial experimentation has been confirmed, providing the initial conditions for knowledge development, diffusion, and legitimation in the early stages of emerging technologies.

Indexed as

artificial intelligencehealth caremedical devicetechnological innovation systemsTIS

Identifiers

PMID41730195
PMCPMC12972688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.